Pyrogen Testing Market Insights: Rising Production of Pharmaceuticals and Biologics Is Driving Market Growth
The global pyrogen
testing market size is expected
to reach a value of USD 1.9 billion by
2025, at a CAGR of 13.4%
according to a new report by Grand View Research, Inc. Increasing demand for
therapeutic drugs including pharmaceuticals, biopharmaceuticals, and biologics
is the major factor that propels growth of the market during forecast period.
Pyrogen is a toxic molecular substance that causes fever if induced in animal
or human body. Pyrogen testing is used by pharmaceutical, biopharmaceuticals,
biotechnology, and medical devices companies to confirm the absence of pyrogen.
Thus, the companies use various methods such as LAL, in vitro pyrogen, and
rabbit test to ensure the quality of products.
Biopharmaceutical innovators are at the
forefront of the human response to the coronavirus pandemic. A significant
number of major biotech firms are in the midst of a race to investigate the
Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the
speed of response to SARS/MERs etc, the biotech entities are investigating
SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are
being put into the R&D. With multiple candidates in trial, the public and
private sectors are anticipated to work in unison for the foreseeable period,
until a vaccine is developed for Covid-19. The report will account for Covid19
as a key market contributor.
Increasing prevalence of chronic
diseases, is another foremost factor supporting the market growth. The
prevalence of chronic diseases is very high in developed countries and is
growing at high pace in developing countries including China and India.
Different factors such as unhealthy diet, smoking, alcohol consumption, and
lack of exercise leads to occurrence of chronic diseases such as cancer,
cardiovascular diseases, diabetes, and chronic respiratory diseases. Hence, there is a growing demand for
therapeutic drugs and medical devices for the treatment of such diseases, which
in turn is projected to fuel the demand for pyrogen testing to ensure the
quality of products including drugs and devices.
Some of the key players in the market
are Merck KGaA; GenScript; Hyglos GmbH;
Ellab A/S; Lonza; Thermo Fisher Scientific, Inc.; Charles River Laboratories,
Inc.; Associates of Cape Cod, Inc.; and Pyrostar. The major companies are
undertaking various strategies initiatives, such as new product development,
mergers, acquisitions, collaborations, and regional expansion for serving the
unmet needs of their customers.
To Request Sample Copy of this report, click the link:
Further key findings from the study suggest:
·
Consumables was the largest
revenue grossing segment of this market in 2016, owing to the large
application of pyrogen testing kits and reagents along with its repetitive
purchase
·
Instruments segment accounted
for the remarkable share in the market in 2016 and is also expected to showcase
significant growth during forecast period, owing to rising demand for
pharmaceutical, biologics, and medical devices for treatment and diagnosis
·
The pharmaceutical and
biotechnology companies segment dominated the pyrogen testing market in terms
of revenue in 2016, due to the large production of therapeutic drugs and
growing investment in R&D by companies for drug development
·
North America is the leading
regional market and accounted for the largest revenue share in 2016 primarily
due to the existence of large number of healthcare companies including
pharmaceuticals and medical devices in this region
·
The Asia Pacific region is
anticipated to be the fastest growing market during the study period. The
growing prevalence rate of chronic diseases in the Asian countries including
India and China, is a major factor contributing to the expansion of market in
this region.
·
Some major players serving this
vertical include Charles River Laboratories, Inc.; Ellab A/S; Merck KGaA;
GenScript; Hyglos GmbH; Lonza; Thermo Fisher Scientific, Inc.; Associates of
Cape Cod, Inc.; and Pyrostar
The
global pyrogen testing market size was valued at over USD 621.8 million in 2016
and is projected to grow at 13.4% over the forecast period. Increasing demand
for pyrogen testing products in pharmaceutical and biotechnology industry is a
major factor contributing towards the growth of the market. Rapidly growing
pharmaceutical and biotechnology industries along with escalating number of new
therapeutics launch is expected to boost the demand for pyrogen testing
products.
Rising
investment in R&D by manufacturing companies and government for new product
development is another major factor contributed towards the growth of the
market. New product development and launch is a key strategy acquired by
manufacturers to maintain their dominance and to get maximum revenue-share in
the sector. As stated by European Federation of Pharmaceutical Industries and
Associations (EFPIA), in Europe, pharmaceutical industry had invested around
USD 43,380 million in R&D in 2014. Thus, the demand for pyrogen testing
products is expected upsurge in near future, which is projected to boost market
growth.
On
the basis of product, the pyrogen testing industry is segmented into
consumables, instruments, and services. In 2016, consumables segment was the
largest revenue-generating segment and is also estimated to maintain its
dominance during the forecast period. Rising prevalence of chronic diseases
boosts the production of pharmaceuticals, biologics, and medical devices
products. Thus, the increasing production of these products propels the
application of pyrogen testing consumables including kits and reagents.
The
instruments segment is expected to show lucrative growth during the forecast
period owing to the technological advancement in products. For instance, the
PyroDetect System is a verified non-animal substitute to replace the rabbit
test that offers a high quality in vitro detection of both non-endotoxin and
endotoxin contamination. In 2016, instruments segment was followed by services
in terms of revenue.
Have any Query? Ask our Experts:
Grand View Research has segmented the
pyrogen testing market on the basis of product, test type, end-use:
Pyrogen Testing Product Outlook (Revenue, USD Million;
2014 - 2025)
·
Consumables
·
Instruments
·
Services
Pyrogen Testing Test Type Outlook (Revenue, USD Million;
2014 - 2025)
·
LAL test
·
Chromogenic test
·
Turbidimetric test
·
Gel clot test
·
In vitro pyrogen
test
·
Rabbit test
Pyrogen Testing End-Use Outlook (Revenue, USD Million;
2014 - 2025)
·
Pharmaceutical and
biotechnology companies
·
Medical devices companies
·
Others
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment